OpenFilings

EyePoint Pharmaceuticals, Inc.

Form8-K

Report Period2024-10-28

Date Filed2024-10-28

Time Filed07:05:18

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

8-K
EX-99.1
EX-99.2
Filing on SEC Edgar